Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease

Sung‐Jin Hong(Inje University Sanggye Paik Hospital), Jung‐Woo Son(Lodestar Research Corporation (United States)), Yangsoo Jang(Yonsei University), Jong‐Youn Kim(Yonsei University), Donghoon Choi(Korea Institute of Science & Technology Information), Jae Kean Ryu(Lodestar Research Corporation (United States)), Pyung Chun Oh(Lodestar Research Corporation (United States)), Jin‐Bae Lee(Daegu Catholic University Medical Center), Myeong‐Ki Hong(Ulsan College), Pil‐Ki Min(Lodestar Research Corporation (United States)), Seung Pyo Hong(Yonsei University), Young Won Yoon(Lodestar Research Corporation (United States)), Sung Gyun Ahn(Lodestar Research Corporation (United States)), Woong Chol Kang(Gachon University), Eui‐Young Choi(Johns Hopkins University), Young‐Guk Ko(Yonsei University), Chang Yeon Kim(Lodestar Research Corporation (United States)), Hyuck Moon Kwon(Severance Hospital), Se‐Joong Rim(Lodestar Research Corporation (United States)), Chul‐Min Ahn(Yonsei University), Jong‐Young Lee(Samsung Medical Center), Jong‐Young Lee(Ulsan College), Seung‐Jun Lee(Yonsei University), Byoung Kwon Lee(Lodestar Research Corporation (United States)), Jung‐Sun Kim(Yonsei University), Hyung-Jin Cho(Lodestar Research Corporation (United States)), Yong‐Joon Lee(Severance Hospital), Tae‐Hyun Yang(Inje University Busan Paik Hospital), Ji Yong Choi(Lodestar Research Corporation (United States)), Junghan Yoon(University of Ulsan), Bum‐Kee Hong(Severance Hospital), Kee Sik Kim(Lodestar Research Corporation (United States)), Byeong‐Keuk Kim(Ewha Womans University)
JAMA
March 6, 2023
Cited by 104


Related Papers